Knockdown of RNF6 inhibits HeLa cervical cancer cell growth via suppression of MAPK/ERK signaling

被引:9
|
作者
Zhu, Kang [1 ]
Bai, He [2 ]
Mu, Mingzhu [1 ]
Xue, Yuanyuan [1 ]
Duan, Zhao [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Xian, Peoples R China
[2] Xian Med Univ, Affiliated Hosp 1, Dept Gen Surg Dept, Xian, Peoples R China
来源
FEBS OPEN BIO | 2021年 / 11卷 / 07期
关键词
cell growth; cervical cancer; ERK; RNF6; PROTEIN; P53; PROLIFERATION; DEGRADATION; EXPRESSION; APOPTOSIS; PATHWAY; ROLES; MDM2; JUN;
D O I
10.1002/2211-5463.13216
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ring finger protein 6 (RNF6) is implicated in various human malignancies, but its function in cervical cancer (CC) is incompletely understood. Here, we explored the biological significance of RNF6 in HeLa CC cells and the underlying regulatory mechanisms. The expression of RNF6 was observed to be high in both primary tissues and CC cells. RNF6 promoted HeLa CC cell growth. Knockdown of RNF6 in CC cells resulted in suppression of proliferation and promotion of apoptosis. Moreover, elevation of RNF6 had an adverse effect on the prognosis of CC. Subsequent analyses showed that these effects may be mediated via activation of ERK signaling. These findings provide evidence that the knockdown of RNF6 suppresses the MAPK/ERK pathway to regulate the growth of CC cells, which suggests that RNF6 may have potential as a target for diagnosis and treatment for CC.
引用
收藏
页码:2041 / 2049
页数:9
相关论文
共 50 条
  • [21] MAGI1 inhibits migration and invasion via blocking MAPK/ERK signaling pathway in gastric cancer
    Shuqin Jia
    Jiajia Lu
    Tingting Qu
    Yi Feng
    Xiaohong Wang
    Caixia Liu
    Jiafu Ji
    Chinese Journal of Cancer Research, 2017, 29 (01) : 25 - 35
  • [22] MAGI1 inhibits migration and invasion via blocking MAPK/ERK signaling pathway in gastric cancer
    Jia, Shuqin
    Lu, Jiajia
    Qu, Tingting
    Feng, Yi
    Wang, Xiaohong
    Liu, Caixia
    Ji, Jiafu
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (01) : 25 - 35
  • [23] Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation
    Wu, Yingting
    Zhu, Feilong
    Sun, Wenqin
    Shen, Weiwei
    Zhang, Qin
    Chen, Huifen
    MOLECULAR MEDICINE REPORTS, 2022, 25 (02)
  • [24] Succinyl rotundic acid inhibits growth and promotes apoptosis in the HeLa cervical cancer cell line
    He, Yufang
    Sun, Jiaming
    Nang, Minlun
    Wang, Xue
    Lin, He
    Lv, Guangfu
    Li, Yong
    Duan, Minghua
    Ye, Hongbo
    MATERIALS EXPRESS, 2020, 10 (04) : 571 - 577
  • [25] Asparanin A inhibits cell migration and invasion in human endometrial cancer via Ras/ERK/MAPK pathway
    Zhang, Fan
    Ni, Zhi-Jing
    Ye, Lei
    Zhang, Yuan-Yuan
    Thakur, Kiran
    Cespedes-Acuna, Carlos L.
    Han, Jinzhi
    Zhang, Jian-Guo
    Wei, Zhao-Jun
    FOOD AND CHEMICAL TOXICOLOGY, 2021, 150
  • [26] Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis
    Han, Bo Ram
    You, Bo Ra
    Park, Woo Hyun
    ONCOLOGY REPORTS, 2013, 30 (06) : 2999 - 3005
  • [27] RING-Finger protein 6 (Rnf6) is upregulated during prostate cancer progression and promotes prostate cancer growth via inducing atypical ubiquitylation of androgen receptor
    Xu, Kexin
    Qiu, Yun
    Shimelis, Hermela
    Yang, Xi
    CANCER RESEARCH, 2008, 68 (09)
  • [28] Cinnamomi Ramulus inhibits the growth of colon cancer cells via Akt/ERK signaling pathways
    Boyu Pan
    Yafei Xia
    Zilu Gao
    Gang Zhao
    Liangjiao Wang
    Senbiao Fang
    Liren Liu
    Shu Yan
    Chinese Medicine, 17
  • [29] Cinnamomi Ramulus inhibits the growth of colon cancer cells via Akt/ERK signaling pathways
    Pan, Boyu
    Xia, Yafei
    Gao, Zilu
    Zhao, Gang
    Wang, Liangjiao
    Fang, Senbiao
    Liu, Liren
    Yan, Shu
    CHINESE MEDICINE, 2022, 17 (01)
  • [30] Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK
    Liang, Xin
    Ju, Jianxin
    ONCOLOGY REPORTS, 2021, 45 (05)